Results 281 to 290 of about 2,362,461 (350)
Some of the next articles are maybe not open access.

Cashew oral immunotherapy for desensitizing cashew‐pistachio allergy (NUT CRACKER study)

Allergy. European Journal of Allergy and Clinical Immunology, 2022
Oral immunotherapy (OIT) is a treatment option for patients with milk, egg, and peanut allergy, but data on the efficacy and safety of cashew OIT are limited.
A. Elizur   +9 more
semanticscholar   +1 more source

Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study

Allergy. European Journal of Allergy and Clinical Immunology, 2022
Oral immunotherapy (OIT) is frequently discontinued due to adverse events (AEs) and current data suggests that lowering OIT doses can minimize severity and frequency of AEs.
S. Sindher   +9 more
semanticscholar   +1 more source

An Approach to the Office-Based Practice of Food Oral Immunotherapy.

Journal of Allergy and Clinical Immunology: In Practice, 2021
Oral immunotherapy (OIT) provides an active treatment option for patients with food allergies. OIT may improve quality of life and raise the threshold at which a patient with food allergy may react to an allergen, but it is a rigorous therapy that ...
R. Wasserman   +13 more
semanticscholar   +1 more source

Oral tolerance and oral immunotherapy for food allergy: Evidence for common mechanisms?

Cellular Immunology, 2022
Food allergies affect up to 10% of the US population, can be life-threatening, and have a significant negative impact on quality of life. Delayed dietary introduction of foods in childhood can hinder the induction of oral tolerance, an active regulatory ...
Wajiha Kazmi, M. Berin
semanticscholar   +1 more source

Oral immunotherapy in pediatrics

Pediatric Allergy and Immunology, 2020
AbstractIgE‐mediated food allergy (FA) has been emerging as a public health priority, mainly in children. It represents a heavy burden for the entire society and not only for the patients and their families. There is evidence that in children with persistent FA, at least to cow's milk, hen's egg, and peanut, oral immunotherapy (OIT) may increase the ...
Arasi S., Castagnoli R., Pajno G. B.
openaire   +4 more sources

Integrating oral immunotherapy into clinical practice.

Journal of Allergy and Clinical Immunology, 2021
In 2020, the first food allergy treatment, an oral immunotherapy (OIT) product for peanut allergy, was approved by the Food and Drug Administration, and a peanut epicutaneous immunotherapy patch was under review.
S. Leonard, S. Laubach, Julie Wang
semanticscholar   +1 more source

Oral immunotherapy in food allergies: A practical update for pediatricians.

Archives de pédiatrie, 2021
Food oral immunotherapy (OIT) is a promising treatment for persistent and severe food allergies (FAs) in children, but also for accelerating tolerance to cow's milk and cooked egg in young children.
M. Sabouraud   +7 more
semanticscholar   +1 more source

Oral Immunotherapy

Canadian Allergy & Immunology Today, 2021
Food allergy affects approximately 7% of the Canadian population and is a lifelong diagnosis for many patients. While fatal anaphylaxis is rare, accidental exposures are common, with many accidental reactions being moderate- to-severe. The fear of severe or fatal anaphylaxis is of major concern and food allergy represents a significant burden on the ...
openaire   +1 more source

Long‐term follow‐up of fixed low‐dose oral immunotherapy for children with severe cow’s milk allergy

Pediatric Allergy and Immunology, 2021
The efficacy and safety of cow's milk (CM) low‐dose oral immunotherapy (LOIT) at one‐year follow‐up have been previously reported. We investigated the outcome of fixed long‐term LOIT in children with severe CM allergy.
Yoko Miura   +9 more
semanticscholar   +1 more source

Oral immunotherapy in severe cow’s milk allergic patients treated with omalizumab: Real life survey from a Spanish registry

Pediatric Allergy and Immunology, 2021
Oral immunotherapy is a frequent treatment for the management of food allergies, but adverse events (AE) are common. This study assessed the outcome of cow's milk oral immunotherapy (MOIT) in severe cow`s milk–allergic patients treated with omalizumab in
M. Ibáñez-Sandín   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy